Kazushi Uneda

1.2k total citations
58 papers, 802 citations indexed

About

Kazushi Uneda is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Kazushi Uneda has authored 58 papers receiving a total of 802 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Cardiology and Cardiovascular Medicine, 21 papers in Endocrinology, Diabetes and Metabolism and 11 papers in Molecular Biology. Recurrent topics in Kazushi Uneda's work include Hormonal Regulation and Hypertension (13 papers), Renin-Angiotensin System Studies (13 papers) and Blood Pressure and Hypertension Studies (10 papers). Kazushi Uneda is often cited by papers focused on Hormonal Regulation and Hypertension (13 papers), Renin-Angiotensin System Studies (13 papers) and Blood Pressure and Hypertension Studies (10 papers). Kazushi Uneda collaborates with scholars based in Japan, Singapore and United States. Kazushi Uneda's co-authors include Kouichi Tamura, Kengo Azushima, Hiromichi Wakui, Satoshi Umemura, Tomohiko Kanaoka, Akio Yamashita, Ryu Kobayashi, Yoshiyuki Toya, Masato Ohsawa and Sho Kinguchi and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Kazushi Uneda

53 papers receiving 793 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kazushi Uneda Japan	17	310	288	207	135	124	58	802
Tomohiko Kanaoka Japan	17	345 1.1×	226 0.8×	142 0.7×	147 1.1×	119 1.0×	51	706
Masato Ohsawa Japan	17	396 1.3×	205 0.7×	158 0.8×	103 0.8×	139 1.1×	45	727
Chao‐Sheng Lo Canada	18	196 0.6×	251 0.9×	424 2.0×	169 1.3×	119 1.0×	34	875
Ryu Kobayashi Japan	15	227 0.7×	162 0.6×	125 0.6×	93 0.7×	81 0.7×	42	521
Bryna S.M. Chow Australia	10	177 0.6×	216 0.8×	326 1.6×	276 2.0×	90 0.7×	12	1.0k
Despina Tsorotes Australia	12	249 0.8×	222 0.8×	333 1.6×	53 0.4×	110 0.9×	12	890
Vajir Malek India	18	230 0.7×	147 0.5×	277 1.3×	101 0.7×	84 0.7×	28	764
Zhi Guo China	12	182 0.6×	144 0.5×	175 0.8×	195 1.4×	107 0.9×	24	874
Deborah Anzalone United States	11	265 0.9×	283 1.0×	91 0.4×	108 0.8×	258 2.1×	19	841
Toru Dejima Japan	15	397 1.3×	187 0.6×	127 0.6×	89 0.7×	79 0.6×	27	580

Countries citing papers authored by Kazushi Uneda

Since Specialization

Citations

This map shows the geographic impact of Kazushi Uneda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazushi Uneda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazushi Uneda more than expected).

Fields of papers citing papers by Kazushi Uneda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazushi Uneda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazushi Uneda. The network helps show where Kazushi Uneda may publish in the future.

Co-authorship network of co-authors of Kazushi Uneda

This figure shows the co-authorship network connecting the top 25 collaborators of Kazushi Uneda. A scholar is included among the top collaborators of Kazushi Uneda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazushi Uneda. Kazushi Uneda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nogami, Tatsuya, Kazushi Uneda, Tetsuhiro Yoshino, et al.. (2025). Survey of attitudes toward clinical research among Japanese traditional (Kampo) medicine specialists and certified doctors affiliated with the Japan Society for Oriental Medicine. Traditional & Kampo Medicine. 12(1). 27–37.

Tahara, Eiichi, et al.. (2025). Survey on Kampo formulas frequently prescribed by physicians belonging to the Japan Society for Oriental Medicine. Traditional & Kampo Medicine. 12(1). 38–46. 1 indexed citations

Uneda, Kazushi, Yuki Kawai, Akira Kaneko, et al.. (2024). Analysis of clinical factors associated with Kampo formula-induced pseudoaldosteronism based on self-reported information from the Japanese Adverse Drug Event Report database. PLoS ONE. 19(1). e0296450–e0296450. 4 indexed citations

Yoshino, Tetsuhiro, Kotoe Katayama, Hiroaki HIKIAMI, et al.. (2024). Machine learning model for predicting the cold–heat pattern in Kampo medicine: a multicenter prospective observational study. Frontiers in Pharmacology. 15. 1412593–1412593.

Kawai, Yuki, et al.. (2024). A pharmacovigilance study on clinical factors of active vitamin D3 analog-related acute kidney injury using the Japanese Adverse Drug Event Report Database. Scientific Reports. 14(1). 21356–21356. 1 indexed citations

Uneda, Kazushi, Tetsuhiro Yoshino, Hidenori Ito, Seiya Imoto, & Tatsuya Nogami. (2024). Current situation and future issues with Kampo medicine: A survey of Japanese physicians. Traditional & Kampo Medicine. 11(2). 156–166. 10 indexed citations

Uneda, Kazushi, et al.. (2024). Encounters with Kampo medicine and its use in current position. Traditional & Kampo Medicine. 11(3). 268–280. 1 indexed citations

Tsukamoto, Shunichiro, Takayuki Yamada, Kazushi Uneda, et al.. (2023). Effects of sodium‐glucose cotransporter 2 inhibitors, mineralocorticoid receptor antagonists, and their combination on albuminuria in diabetic patients. Diabetes Obesity and Metabolism. 25(5). 1271–1279. 7 indexed citations

Tsukamoto, Shunichiro, Shohei Tanaka, Takayuki Yamada, et al.. (2023). Effect of tirzepatide on glycaemic control and weight loss compared with other glucagon‐like peptide‐1 receptor agonists in Japanese patients with type 2 diabetes mellitus. Diabetes Obesity and Metabolism. 26(1). 262–274. 13 indexed citations

10.

Kawai, Yuki, Kayo Waki, Satoko Yamaguchi, et al.. (2022). The Use of Information and Communication Technology–Based Self-management System DialBeticsLite in Treating Abdominal Obesity in Japanese Office Workers: Prospective Single-Arm Pilot Intervention Study. JMIR Diabetes. 7(4). e40366–e40366. 3 indexed citations

11.

Uneda, Kazushi, Yuki Kawai, Takayuki Yamada, et al.. (2022). Japanese traditional Kampo medicine bofutsushosan improves body mass index in participants with obesity: A systematic review and meta-analysis. PLoS ONE. 17(4). e0266917–e0266917. 11 indexed citations

12.

Uneda, Kazushi, et al.. (2021). Therapeutic potential of ubaien for refractory gastrointestinal diseases: Japanese case reports and literature review. Traditional & Kampo Medicine. 8(3). 234–237. 1 indexed citations

13.

Tsukamoto, Shunichiro, Takayuki Yamada, Kengo Azushima, et al.. (2021). Prevention of kidney function decline using uric acid-lowering therapy in chronic kidney disease patients: a systematic review and network meta-analysis. Clinical Rheumatology. 41(3). 911–919. 29 indexed citations

14.

Urate, Shingo, Hiromichi Wakui, Kengo Azushima, et al.. (2021). Aristolochic Acid Induces Renal Fibrosis and Senescence in Mice. International Journal of Molecular Sciences. 22(22). 12432–12432. 22 indexed citations

15.

Kawai, Yuki, Kazushi Uneda, Takayuki Yamada, et al.. (2021). Comparison of effects of SGLT-2 inhibitors and GLP-1 receptor agonists on cardiovascular and renal outcomes in type 2 diabetes mellitus patients with/without albuminuria: A systematic review and network meta-analysis. Diabetes Research and Clinical Practice. 183. 109146–109146. 28 indexed citations

16.

Haku, Sona, Hiromichi Wakui, Kengo Azushima, et al.. (2018). Early Enhanced Leucine-Rich α-2-Glycoprotein-1 Expression in Glomerular Endothelial Cells of Type 2 Diabetic Nephropathy Model Mice. BioMed Research International. 2018. 1–9. 24 indexed citations

17.

Tamura, Kouichi, Hiromichi Wakui, Kengo Azushima, Kazushi Uneda, & Satoshi Umemura. (2016). Circadian blood pressure rhythm as a possible key target of SGLT2 inhibitors used for the treatment of Type 2 diabetes. Hypertension Research. 39(6). 396–398. 16 indexed citations

18.

Ohsawa, Masato, Kouichi Tamura, Hiromichi Wakui, et al.. (2015). Effects of pitavastatin add-on therapy on chronic kidney disease with albuminuria and dyslipidemia. Lipids in Health and Disease. 14(1). 161–161. 8 indexed citations

19.

Matsuda, Miyuki, Kouichi Tamura, Hiromichi Wakui, et al.. (2013). Upstream Stimulatory Factors 1 and 2 Mediate the Transcription of Angiotensin II Binding and Inhibitory Protein. Journal of Biological Chemistry. 288(26). 19238–19249. 14 indexed citations

20.

Tamura, Kouichi, Akinobu Maeda, Kazushi Uneda, et al.. (2012). An increase in perfusion pressure and activation of the renin–angiotensin system in the pathogenesis of hypertension and injury: strain vessels and the cerebrovascular-renal connection. Hypertension Research. 35(10). 972–974. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact